{
     "PMID": "11549378",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20011207",
     "LR": "20131121",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "913",
     "IP": "2",
     "DP": "2001 Sep 21",
     "TI": "Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI.",
     "PG": "149-55",
     "AB": "Brain blood volume changes in the rat in response to 5-HT(1A) agonist and antagonist administration were measured using susceptibility contrast enhanced magnetic resonance imaging (MRI). Administration of the 5-HT(1A) agonist 8-OH-DPAT resulted in decreases in fractional brain blood volumes. Administration of the 5-HT(1A) antagonist WAY-100635 following a dose of 8-OH-DPAT resulted in increases in fractional blood volumes greatest in hippocampus and cortex and smallest in thalamus and caudate-putamen. The magnitude of the regional increases in blood volumes paralleled the distribution of 5-HT(1A) receptors in the rat brain. Administration of WAY-100635 alone resulted in decreases in cortical blood volume and increases in cerebellar blood volume.",
     "FAU": [
          "Scanley, B E",
          "Kennan, R P",
          "Gore, J C"
     ],
     "AU": [
          "Scanley BE",
          "Kennan RP",
          "Gore JC"
     ],
     "AD": "Department of Psychiatry, Yale University School of Medicine, Fitkin B27, P.O. Box 208042, New Haven, CT 06520-8042, USA. ellen.scanley@yale.edu",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Contrast Media)",
          "0 (Piperazines)",
          "0 (Pyridines)",
          "0 (Receptors, Serotonin)",
          "0 (Receptors, Serotonin, 5-HT1)",
          "0 (Serotonin Antagonists)",
          "0 (Serotonin Receptor Agonists)",
          "333DO1RDJY (Serotonin)",
          "71IH826FEG",
          "(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxa",
          "mide)",
          "78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin)"
     ],
     "SB": "IM",
     "MH": [
          "8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology",
          "Animals",
          "Blood Pressure/drug effects/physiology",
          "Blood Volume/drug effects/physiology",
          "Brain/blood supply/*drug effects/metabolism",
          "Cerebrovascular Circulation/*drug effects/physiology",
          "Contrast Media/pharmacokinetics",
          "Dose-Response Relationship, Drug",
          "Drug Interactions/physiology",
          "Female",
          "Magnetic Resonance Imaging/*methods",
          "Neurons/drug effects/metabolism",
          "Piperazines/pharmacology",
          "Pyridines/pharmacology",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, Serotonin/*drug effects/metabolism",
          "Receptors, Serotonin, 5-HT1",
          "Serotonin/*metabolism",
          "Serotonin Antagonists/*pharmacology",
          "Serotonin Receptor Agonists/*pharmacology"
     ],
     "EDAT": "2001/09/11 10:00",
     "MHDA": "2002/01/05 10:01",
     "CRDT": [
          "2001/09/11 10:00"
     ],
     "PHST": [
          "2001/09/11 10:00 [pubmed]",
          "2002/01/05 10:01 [medline]",
          "2001/09/11 10:00 [entrez]"
     ],
     "AID": [
          "S0006-8993(01)02771-8 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2001 Sep 21;913(2):149-55.",
     "term": "hippocampus"
}